Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FMTX

Forma Therapeutics (FMTX) Stock Price, News & Analysis

Forma Therapeutics logo

About Forma Therapeutics Stock (NASDAQ:FMTX)

Advanced Chart

Key Stats

Today's Range
$20.01
$20.01
50-Day Range
$19.91
$20.01
52-Week Range
$4.95
$20.68
Volume
1 shs
Average Volume
847,595 shs
Market Capitalization
$957.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forma Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FMTX Stock News Headlines

Forma Therapeutics Holdings, Inc. (FMTX)
One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
4 Analysts Have This to Say About Forma Therapeutics Hldgs
Forma Therapeutics: Rare Disease Play
Novo Nordisk To Acquire Forma Therapeutics - Quick Facts
See More Headlines

FMTX Stock Analysis - Frequently Asked Questions

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) announced its earnings results on Friday, November, 12th. The company reported ($0.91) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.96) by $0.05.

Forma Therapeutics (FMTX) raised $201 million in an initial public offering (IPO) on Friday, June 19th 2020. The company issued 11,800,000 shares at $16.00-$18.00 per share. Jefferies' SVB Leerink and Credit Suisse served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Forma Therapeutics investors own include Tesla (TSLA), HubSpot (HUBS), Cheniere Energy (LNG), Netflix (NFLX), Marvell Technology (MRVL) and Viper Energy (VNOM).

Company Calendar

Last Earnings
11/12/2021
Today
8/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:FMTX
CIK
1538927
Fax
N/A
Employees
166
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$172.96 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-39.68%
Return on Assets
-35.33%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.74
Quick Ratio
12.74

Sales & Book Value

Annual Sales
$100.56 million
Price / Sales
9.52
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.51 per share
Price / Book
1.90

Miscellaneous

Outstanding Shares
47,853,000
Free Float
45,082,000
Market Cap
$957.54 million
Optionable
Not Optionable
Beta
-0.94

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:FMTX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners